Скачать
Industry Update: REGENXBIO
Автор: DefeatDuchenne
Загружено: 2025-07-02
Просмотров: 984
Описание:
On June 23, 2025, Defeat Duchenne Canada hosted an educational webinar featuring Dr. Jahannaz Dastgir, Executive Director of Clinical Development at REGENXBIO. Dr. Dastgir shared the latest updates on RGX-202, an investigational gene therapy for #Duchenne #musculardystrophy, along with insights from the Phase 1/2/3 AFFINITY DUCHENNE® trial.
The session offered valuable information on the science behind RGX-202, the current status of the clinical trial, and its potential impact on the Duchenne community.
👉 Stay informed about upcoming Duchenne webinars: https://defeatduchenne.ca/webinars
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке:
